RAD51 and ovarian cancer: We previously reported that induction of nuclear RAD51 foci by PARPi olaparib was significantly attenuated by CHK1i Prex in ovarian cancer cells, thus sensitizing BRCAwt HGSOC to PARPi via causing an HR-deficient phenotype [7].